New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
Jae Sik KimKyubo KimWonguen JungKyung Hwan ShinSeock-Ah ImHee-Jun KimYong Bae KimJee Suk ChangJee Hyun KimDoo Ho ChoiYeon Hee ParkDae Yong KimTae Hyun KimByung Ock ChoiSea-Won LeeSuzy KimJeanny KwonKi Mun KangWoong-Ki ChungKyung Su KimWon Sup YoonJin Hee KimJihye ChaYoon Kyeong OhIn Ah KimPublished in: Breast cancer research and treatment (2021)
Tumor molecular subtypes were associated with both rates of new BM development and the effectiveness of initial WBRT. Anti-HER2 therapy in HER2+ patients significantly lowered new BM occurrence.
Keyphrases
- brain metastases
- small cell lung cancer
- end stage renal disease
- newly diagnosed
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- systematic review
- early stage
- risk assessment
- radiation therapy
- resting state
- white matter
- stem cells
- locally advanced
- squamous cell carcinoma
- multiple sclerosis
- radiation induced
- functional connectivity
- cell therapy